The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

But all of those promises have turned out to be overstated or simply wrong. Legalization has raised cannabis consumption ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...